Patient Power®
Get Email Alerts!
Health Topics
Multiple Myeloma Health Center
Health Center Home Audio Programs Videos Conference Coverage
  • ASH 2011
    • Live Events
  • SCCA Myeloma Town Hall 2011
    • Search by Keyword:
    Search by Health Topic:
    View all Health Topics >
    Spring Survey Results 2012

    Ask the Expert about the Latest Myeloma News

    PROGRAM DETAILS:

    The American Society of Hematology has a conference each year, where about 30,000 experts in blood-related cancers gather from around the world to discuss their latest research. On this show, host Andrew Schorr is joined by Dr. Sagar Lonial, a myeloma specialist in Atlanta. Dr. Lonial is an associate professor at the Winship Cancer Institute of Emory University, and also Director of Translational Research in the B-cell Malignancy Program there. They discuss the findings from this year’s ASH conference and take calls and emails from listeners.

    Dr. Sagar Lonial explains why this is a pivotal time in myeloma research. As more research and techniques become available, it’s important to think about how these therapies all work together. The discussion focuses on combination therapy, including transplant and several drug therapies. He speaks about promising new drugs, how to choose the right treatment and how doctors are improving transplants.

    We also hear from patients from around the country with questions about specific drugs and other treatments. Dr. Lonial helps them to decide how to know when to call your doctor when side effects get too bad, and gives advice about what patients can do on their own to improve their chances for recovery, as well as treatment options to discuss with their doctors. He also answers questions about the role heredity might play, and how a patient’s age might affect which therapies are used.

    Tune in to this show to learn about the differences between specific drugs and therapies, as well as new technologies that are making this an exciting time in myeloma research and treatment. While there may bumps in the road in myeloma treatment, these new technologies have suggested myeloma patients can now live long, full lives while undergoing occasional treatment. Dr. Lonial says, “a main goal for all of us who treat myeloma is that we want patients to be back doing what they normally do and enjoying life and spending time with their family.”

    Get Email Updates:

    Get updated automatically when new content about Multiple Myeloma has been posted.
    Privacy Policy
    Multiple Myeloma
    EXPERTS & GUESTS:
    Sagar Lonial, M.D. Sagar Lonial, M.D.
    Associate Professor, Emory Healthcare
    Dr. Sagar Lonial is an Associate Professor at the Winship Cancer Institute of Emory University, and is also Director of Translational Research, B-cell malignancy program. He is on staff and works both on the bone marrow transplant service as well as in the B-cell malignancy clinic. Dr. Lonial completed his Hematology-Oncology training at Emory University, and prior to that received... more >

    TRANSCRIPT:

    1. Introduction LISTEN
    2. What’s Encouraging about the Latest Data? LISTEN
    3. The Role of Transplant LISTEN
    4. Dr. Lonial Answers Questions from Listeners LISTEN
    5. Where is Research Headed? LISTEN

    RELATED LINKS: